Periodic Reporting for period 4 - CaNANObinoids (From Peripheralized to Cell- and Organelle-Targeted Medicine: The 3rd Generation of Cannabinoid-1 Receptor Antagonists for the Treatment of Chronic Kidney Disease)

Chronic kidney disease (CKD), a distinct manifestation of diabetic renal disease that is seen in patients with both type 1 and type 2 diabetes, is also a significant epidemiologic problem and is thought to affect around 8% of the European population. A decade ago, most...